| Name/Institution/Title | Co-applicants | Term (years) |
1st Year amount | Total Amount approved |
|---|---|---|---|---|
| KOVACS, Michael J. London Health Sciences Centre A double blind randomized control trial of post-operative low molecular weight heparin bridging therapy versus placebo bridging therapy for patients who are at high risk for arterial thromboembolism* |
Rodger, M.A., Anderson, D.R., Wells, P.S., Kearon, C., Bates, S.M., Kahn, S.R., Solymoss, S., Shulman, S., Blostein, M.D. | 5 | $537,378 | $2,312,255 |
| KUMAR, Deepali University Health Network (Toronto) Immunogenicity of pneumococcal vaccine in liver transplant recipients |
Humar, A., McGeer,A.J., Levy, G.A. |
3 | $128,560 | $320,776 |
| MALTAIS, François Université Laval Effects of a home-based vs hospital based outpatient pulmonary rehabilitation program in patients with COPD: A multicenter, randomized controlled trial* |
Bourbeau, J., Baltzan, M., Perrault, H., Lacasse, Y., Shapiro, S., Penrod, J.R. | 1 | $280,470 | $280,470 |
| MEHTA, Shamir McMaster University Early versus delayed invasive strategies in patients with acute coronary syndromes* |
Yusuf, S., Natarajan, M.K., Pogue, J.M., Lamy, A., Gafni, A. | 3 | $218,873 | $457,767 |
| MOLLOY, David W. McMaster University Multi-centre, blinded, randomized, controlled trial comparing different regimens of the antibiotics doxycycline and rifampin for treatment of Alzheimer's disease* |
Lewis, D.L., Borrie, M.J., Patterson, C.J., Decoteau, W.E., Jarrett, P.G., Woo, T.K., Chivers, R., MacKnight, C.R., Rockwood, K., Heckman, G.A., Black, S.E., Guyatt, G.H. | 3.5 | $516,382 | $1,867,141 |
| MORILLO, Carlos A. McMaster University Benznidazole evaluation for interrupting trypanosomiasis pilot trial (BENEFIT)* |
Yusuf, S., Connolly, S.J., Marin-Neto, S.J., Rassis Jr., A., Avezum, A., Sosa-Estani, S.A., Villar, J.C. | 3 | $322,430 (includes $9,313 for equipment) | $866,435 |
| SCHMIDT, Barbara K. McMaster University Efficacy and safety of targeting lower arterial oxygen saturations to reduce oxygen toxicity and oxidative stress in very preterm infants: The Canadian oxygen trial (COT)* |
Roberts, R.S., Whyte, R.K., Asztalos, E.V., Shah, P., Solimano, A.J., Bairam, A., Seshia, M., Moddeman, D.M., Chiu, A., Roukema, H.W., Sauve, R.S., Rabi., J., Harrold, J.E., Clarke, M.C.W., Kumar, M., Peliowski. | 5 | $776,972 | $3,884,860 |
| SPENCE, John D. John P. Robarts Research Institute Effect of L-thyroxine on progression of carotid atherosclerosis in subclinical hypothyroidism |
House, A.W., Edmonds, M.W., Parraga, G. | 3 | $156,431 | $451,071 |
| ZELKOWITZ, Phyllis Sir Mortimer B. Davis Jewish General Hospital A trial of a skills-based intervention to reduce maternal anxiety and improve developmental outcomes in very low birthweight infants* |
Feeley, N., Papageorgiou, A.N., Lefebvre, F., Westreich, R., Dunkley, D.M., Shrier, I., Roseberger, Z., Steele, R.J., Stremler, R.L. | 4 | $106,659 (includes $5,350 for equipment) | $338,472 |
* indicates a multicentre study
